Cargando…
Comparing pregabalin and gabapentin for persistent neuropathic pain: A protocol for a pilot N-of-1 trial series
BACKGROUND: Evidence-based management of neuropathic pain is commonly ineffective due to the large variability in response between cases. Patients often have to trial several drugs before finding one that provides adequate relief, leading to increased costs and worsened outcomes. There is thus a nee...
Autores principales: | Bashford, Guy, Tan, Samuel X., McGree, James, Murdoch, Veronica, Nikles, Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556752/ https://www.ncbi.nlm.nih.gov/pubmed/34754981 http://dx.doi.org/10.1016/j.conctc.2021.100852 |
Ejemplares similares
-
Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic pain
por: Quilici, Sibilia, et al.
Publicado: (2009) -
Gabapentinoids: Gabapentin and Pregabalin for Postoperative Pain Management
por: Imani, Farnad, et al.
Publicado: (2012) -
Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity
por: Sicras‐Mainar, Antoni, et al.
Publicado: (2016) -
Pregabalin and Gabapentin in Patients with Spinal Cord Injury-Related Neuropathic Pain: A Network Meta-Analysis
por: Tong, Chen, et al.
Publicado: (2021) -
Pregabalin and gabapentin in neuropathic pain management after spinal cord injury: a systematic review and meta-analysis
por: Davari, Majid, et al.
Publicado: (2020)